Cargando…
Bone Marrow Mesenchymal Stem Cells in Acute-on-Chronic Liver Failure Grades 2 and 3: A Phase I-II Randomized Clinical Trial
INTRODUCTION: Acute-on-chronic liver failure (ACLF) is an acute liver decompensation in cirrhotic patients, which leads to organ failures and high short-term mortality. The treatment is based on the management of complications and, in severe cases, liver transplantation. Since specific treatment is...
Autores principales: | Schacher, Fernando Comunello, Martins Pezzi da Silva, Annelise, Silla, Lucia Mariano da Rocha, Álvares-da-Silva, Mario Reis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357501/ https://www.ncbi.nlm.nih.gov/pubmed/34395335 http://dx.doi.org/10.1155/2021/3662776 |
Ejemplares similares
-
Mesenchymal stem cell therapy and acute graft-versus-host disease: a review
por: Amorin, Bruna, et al.
Publicado: (2014) -
Bone marrow transplantation and acute myeloid leukemia: Brazilian guidelines
por: Silla, Lucia Mariano da Rocha, et al.
Publicado: (2013) -
High Prevalence of Multidrug Resistant Bacteria in Cirrhotic Patients with Spontaneous Bacterial Peritonitis: Is It Time to Change the Standard Antimicrobial Approach?
por: Oliveira, Jerônimo De Conto, et al.
Publicado: (2019) -
Erratum to “DNMT3A Mutations in Patients with Acute Myeloid Leukemia in South Brazil”
por: Pezzi, Annelise, et al.
Publicado: (2014) -
DNMT3A Mutations in Patients with Acute Myeloid Leukemia in South Brazil
por: Pezzi, Annelise, et al.
Publicado: (2012)